Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy.

Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy.

OBJECTIVES: We investigated cardiac energetics in subjects with mutations in three different familial hypertrophic cardiomyopathy (HCM) disease genes, some of whom were nonpenetrant carriers without hypertrophy, using phosphorus-31 magnetic resonance spectroscopy. BACKGROUND: Familial hypertrophic c...

書誌詳細
主要な著者:	Crilley, J, Boehm, E, Blair, E, Rajagopalan, B, Blamire, A, Styles, P, McKenna, W, Ostman-Smith, I, Clarke, K, Watkins, H
フォーマット:	Journal article
言語:	English
出版事項:	2003

類似資料

Regression of Left Ventricular Hypertrophy in a Case of Sarcomeric Hypertrophic Cardiomyopathy
著者:: Eva Cabrera Borrego, MD, 等
出版事項: (2020-06-01)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
著者:: Hudsmith, L, 等
出版事項: (2006)

Left Atrial structure and function in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy
著者:: Hoshang Farhad, 等
出版事項: (2017-12-01)

Sarcomere mutation negative hypertrophic cardiomyopathy is associated with ageing and obesity
著者:: Alejandro E de Feria, 等
出版事項: (2021-02-01)

A Contraction Stress Model of Hypertrophic Cardiomyopathy due to Sarcomere Mutations
著者:: Rachel Cohn, 等
出版事項: (2019-01-01)

Childhood Hypertrophic Cardiomyopathy: A Disease of the Cardiac Sarcomere
著者:: Gabrielle Norrish, 等
出版事項: (2021-07-01)

Biomarkers and Proteomics in Sarcomeric Hypertrophic Cardiomyopathy in the Young—FGF-21 Highly Associated with Overt Disease
著者:: Anna Wålinder Österberg, 等
出版事項: (2024-03-01)

Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy.
著者:: Geier, C, 等
出版事項: (2008)

Double mutations in CIS can confound genotype-phenotype correlations in hypertrophic cardiomyopathy
著者:: Blair, E, 等
出版事項: (2000)

The genetics of hypertrophic cardiomyopathy: Teare redux.
著者:: Watkins, H, 等
出版事項: (2008)

Multimodality Imaging in Sarcomeric Hypertrophic Cardiomyopathy: Get It Right…on Time
著者:: Alessandro Galluzzo, 等
出版事項: (2023-01-01)

Sarcomeric hypertrophic cardiomyopathy: Genetic profile in a Portuguese population
著者:: Dulce Brito, 等
出版事項: (2012-09-01)

The prognostic impact of septal myectomy in obstructive hypertrophic cardiomyopathy.
著者:: Watkins, H, 等
出版事項: (2005)

Disruption of embryonic ROCK signaling reproduces the sarcomeric phenotype of hypertrophic cardiomyopathy
著者:: Kate E. Bailey, 等
出版事項: (2020-12-01)

Mutations in cis can confound genotype-phenotype correlations in hypertrophic cardiomyopathy.
著者:: Blair, E, 等
出版事項: (2001)

Hypertrophic Cardiomyopathy in Children: Pathophysiology, Diagnosis, and Treatment of Non-sarcomeric Causes
著者:: Emanuele Monda, 等
出版事項: (2021-02-01)

Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes
著者:: Walsh, R, 等
出版事項: (2017)

THE SPECIFICS OF HYPERTROPHIC CARDIOMYOPATHY CLINICAL PRESENTATION IN PATIENTS WITH VARIOUS MUTATIONS OF SARCOMERE GENES
著者:: S. M. Komissarova, 等
出版事項: (2016-01-01)

Disease pathways and novel therapeutic targets in hypertrophic cardiomyopathy.
著者:: Ashrafian, H, 等
出版事項: (2011)

The Definition of Sarcomeric and Non-Sarcomeric Gene Mutations in Hypertrophic Cardiomyopathy Patients: A Multicenter Diagnostic Study Across Türkiye
著者:: Veysel Oktay, 等
出版事項: (2023-10-01)

Contribution of hypoxia-inducible factor 1alpha to pathogenesis of sarcomeric hypertrophic cardiomyopathy
著者:: Sarala Raj Murthi, 等
出版事項: (2025-01-01)

Contribution of hypoxia-inducible factor 1alpha to pathogenesis of sarcomeric hypertrophic cardiomyopathy
著者:: Raj Murthi, S, 等
出版事項: (2025)

Effect of sarcomere and mitochondria-related mutations on myocardial fibrosis in patients with hypertrophic cardiomyopathy
著者:: Hyemoon Chung, 等
出版事項: (2021-03-01)

Contribution of sarcomere gene mutations to left atrial function in patients with hypertrophic cardiomyopathy
著者:: Hyemoon Chung, 等
出版事項: (2021-01-01)

Myosin sequestration regulates sarcomere function, cardiomyocyte energetics, and metabolism, informing the pathogenesis of hypertrophic cardiomyopathy
著者:: Toepfer, CN, 等
出版事項: (2020)

Ascertainment strategies and genotype:phenotype correlations in hypertrophic cardiomyopathy.
著者:: Blair, E, 等
出版事項: (2003)

Linked genetic modifiers in hypertrophic cardiomyopathy
著者:: Ektisham, J, 等
出版事項: (2004)

Subaortic and midventricular obstructive hypertrophic cardiomyopathy with extreme segmental hypertrophy
著者:: Karoulas Takis, 等
出版事項: (2007-03-01)

Analysis of 51 proposed hypertrophic cardiomyopathy genes from genome sequencing data in sarcomere negative cases has negligible diagnostic yield
著者:: Thomson, K, 等
出版事項: (2018)

Assessment of myocardial work in sarcomere gene mutation carriers, healthy controls and overt nonobstructive hypertrophic cardiomyopathy
著者:: Carla Marques Pires, 等
出版事項: (2025-02-01)

Proteomic and phosphoproteomic analyses of myectomy tissue reveals difference between sarcomeric and genotype-negative hypertrophic cardiomyopathy
著者:: Ramin Garmany, 等
出版事項: (2023-09-01)

Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.
著者:: Ashrafian, H, 等
出版事項: (2003)

Early onset malignant hypertrophic cardiomyopathy caused by mutations in MYBPC3
著者:: Carballo, S, 等
出版事項: (2003)

A new variant of apical hypertrophic cardiomyopathy? T wave inversion and relative but not absolute apical left ventricular hypertrophy
著者:: Flett Andrew, 等
出版事項: (2013-01-01)

Atrial Fibrillation in Hypertrophic Cardiomyopathy: Is the Extent of Septal Hypertrophy Important?
著者:: Kyoung-Min Park, 等
出版事項: (2016-01-01)

Magnetic resonance spectroscopy evidence of abnormal cardiac energetics in Xp21 muscular dystrophy.
著者:: Crilley, J, 等
出版事項: (2000)

Mutations of the light meromyosin domain of the beta-myosin heavy chain rod in hypertrophic cardiomyopathy.
著者:: Blair, E, 等
出版事項: (2002)

Novel mutations in cardiac MYBPC3 and early onset malignant hypertrophic cardiomyopathy
著者:: Carballo, S, 等
出版事項: (2005)

Derangement of cardiac energy metabolism is acutely exacerbated during exercise in hypertrophic cardiomyopathy, independent of hypertrophy or late gadolinium burden
著者:: Dass Sairia, 等
出版事項: (2012-02-01)

Hypertrophic cardiomyopathy mutations in the gamma 2 subunit of AMP-activated kinase suggest a central role of energy compromise in disease pathogenesis
著者:: Blair, E, 等
出版事項: (2001)